Individualisation of hypertensive therapy - β-blockers offer a spectrum of options Newsletter Article 20 February 2013 Pages: 2 - 2
The combined use of theophylline and β2-agonists in chronic bronchitis and emphysema Newsletter Article 20 February 2013 Pages: 2 - 3
Are antimicrobials of value in febrile children with possible occult bacteraemia? Newsletter Article 20 February 2013 Pages: 3 - 3
Pondering priorities in coronary heart disease prevention Newsletter Article 20 February 2013 Pages: 3 - 3
Will thrombolysis after MI confer long term benefit? Newsletter Article 20 February 2013 Pages: 3 - 4
Young men with hypercholesterolaemia should benefit most from treatment with lipid lowering agents Newsletter Article 20 February 2013 Pages: 4 - 4
Cetirizine 10mg: is equipotent to terfenadine 180mg in inhibiting histamine skin reactivity Newsletter Article 20 February 2013 Pages: 4 - 5
Ifoxetine: is well tolerated in the 50-150 mg/day therapeutic dose range Newsletter Article 20 February 2013 Pages: 5 - 5
Miglitol: and emiglitate attenuate postprandial increases in blood glucose levels in diabetics Newsletter Article 20 February 2013 Pages: 5 - 5
Amfebutamone: does not produce cardiovascular side effects whereas the use of imipramine is limited by hypotension Newsletter Article 20 February 2013 Pages: 5 - 5
Citalopram: appears to have similar efficacy but different adverse effects to maprotiline in hospitalised depressed patients Newsletter Article 20 February 2013 Pages: 5 - 6
Sucralfate Proves to be a Valid Alternative in Oesophagitis Newsletter Article 20 February 2013 Pages: 6 - 6
Fewer Complications Occur with Cefotaxime + Vancomycin … Newsletter Article 20 February 2013 Pages: 7 - 7
Dihydroergotamine Mesylate in Herpes Simplex Infections … Newsletter Article 20 February 2013 Pages: 8 - 8
Amoxicillin Confers Limited Benefit in Suspected Bacteraemia Newsletter Article 20 February 2013 Pages: 8 - 8
Nalbuphine Provides Safe and Effective Pain Relief in Suspected MI Newsletter Article 20 February 2013 Pages: 8 - 8
Enalapril and Atenolol Show Similar Antihypertensive Efficacy Newsletter Article 20 February 2013 Pages: 8 - 9
Maintenance with Cyclophosphamide in Progressive Multiple Sclerosis Newsletter Article 20 February 2013 Pages: 9 - 9
Intravenous Iloprost vs Hetastarch in Intermittent Claudication Newsletter Article 20 February 2013 Pages: 9 - 9
Timolol/Bendroflumethiazide As Long Term Therapy in Hypertension Newsletter Article 20 February 2013 Pages: 12 - 12
Intracoronary Streptokinase + Isosorbide Dinitrate Therapy Newsletter Article 20 February 2013 Pages: 12 - 13
Cefuroxime Axetil Cures Upper Respiratory Tract Infections Newsletter Article 20 February 2013 Pages: 13 - 13
Prophylactic Use of Cytomegalovirus Immunoglobulin … Newsletter Article 20 February 2013 Pages: 13 - 13
Both Nortriptyline and Phenelzine are Effective in Depression Newsletter Article 20 February 2013 Pages: 13 - 14
A Twice-Daily Sucralfate Regimen May Improve Patient Compliance Newsletter Article 20 February 2013 Pages: 14 - 14
Cefotaxime is More Cost-Effective than Ceftriaxone Newsletter Article 20 February 2013 Pages: 14 - 14
Metoprolol Fails to Improve Left Ventricular Function or Infarct Size Newsletter Article 20 February 2013 Pages: 14 - 15
Paracetamol and Piroxicam are Both Effective in Relieving Episiotomy Pain Newsletter Article 20 February 2013 Pages: 15 - 15
Aiming Amiodarone at Refractory Atrial Fibrillation Newsletter Article 20 February 2013 Pages: 15 - 15
Labetalol Beats Methyldopa for Hypertension in Pregnancy Newsletter Article 20 February 2013 Pages: 16 - 16
Rapid Correction of Symptomatic Hyponatraemia is Safe Newsletter Article 20 February 2013 Pages: 16 - 16
Chronic Therapy with Molsidomine Does Not Produce Tolerance Newsletter Article 20 February 2013 Pages: 17 - 17
Human insulin - a logical choice for newly diagnosed diabetics Newsletter Article 20 February 2013 Pages: 17 - 18
NSAIDs in pain: investigations of the analgesic efficacy of ketoprofen … (continued) Newsletter Article 20 February 2013 Pages: 19 - 20